Additional information
| Product Name | SARIMOX CV 457 DT Tablet |
|---|---|
| Generic Name | Amoxicillin + Clavulanic Acid |
| Composition | Each uncoated dispersible tablet contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 400 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 57 mg |
| Dosage Form | |
| Therapeutic Categories | Antibacterials / Antimicrobials / Antidiarrheals / G. I. Anti Infections |
| Drug Class | Penicillin-Class Antibacterial + Beta-Lactamase Inhibitor |
| Indication | Treatment of susceptible bacterial infections for which amoxicillin/clavulanate is clinically appropriate. Depending on the infection and approved labeling, uses include respiratory tract infections, acute bacterial otitis media, sinusitis, skin/skin-structure infections and urinary tract infections. |
| Target Infections - Conditions | Susceptible bacterial respiratory tract infections, Acute bacterial otitis media, Bacterial sinusitis, Susceptible skin and skin-structure infections, Susceptible urinary tract infections |
| Strength | Amoxicillin 400 mg + Clavulanic Acid 57 mg |
| Pack Size | 10 ? 1 ? 10 Tablets |
| Packaging Type | Aluminium Strip |
| Storage Conditions | Store in a cool and dry place below 25?C. Protect from moisture and direct sunlight. |
| Prescription Status | Rx (To be taken under medical supervision) |
